A phase I/II study of HB-201, an arenavirus-based cancer immunotherapy, alone, or in combination with anti-PD-1 in patients with HPV16(+) cancers Meeting Abstract
| Authors: | Burman, B.; Niu, J.; Leidner, R. S.; Wang, D.; Richardson, D. L.; Iacobucci, C.; Hwang, A.; Qing, X.; Matushansky, I.; Zamarin, D.; Ho, A. L.; Pfister, D. G.; Posner, M. R. |
| Abstract Title: | A phase I/II study of HB-201, an arenavirus-based cancer immunotherapy, alone, or in combination with anti-PD-1 in patients with HPV16(+) cancers |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368309085 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.TPS3171 |
| Notes: | Meeting Abstract: TPS3171 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work